Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

Kan Yonemori; Akihiro Hirakawa; Masashi Ando; Taizo Hirata; Mayu Yunokawa; Chikako Shimizu; Kenji Tamura; Yasuhiro Fujiwara

doi:10.1371/journal.pone.0044393

Loading metrics

Open Access

Peer-reviewed

Research Article

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

Kan Yonemori ,

* E-mail: kyonemor@ncc.go.jp

Affiliation Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
⨯
Akihiro Hirakawa,

Affiliation Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, Aichi, Japan
⨯
Masashi Ando,

Affiliation Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
⨯
Taizo Hirata,

Affiliation Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
⨯
Mayu Yunokawa,

Affiliation Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
⨯
Chikako Shimizu,

Affiliation Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
⨯
Kenji Tamura,

Affiliation Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
⨯
Yasuhiro Fujiwara

Affiliation Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
⨯

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

Kan Yonemori,
Akihiro Hirakawa,
Masashi Ando,
Taizo Hirata,
Mayu Yunokawa,
Chikako Shimizu,
Kenji Tamura,
Yasuhiro Fujiwara

Published: August 31, 2012
https://doi.org/10.1371/journal.pone.0044393

Reader Comments

Post a new comment on this article

An interesting benchmark

Posted by Athena1 on 10 Sep 2012 at 09:00 GMT

Although the research was limited to a single oncology journal, I found these results interesting and informative. I would not have guessed that ads calling for clinical trial participation would be the category of ads that is notably rising over time. Does this help us understand the motivations of pharmaceutical companies?

No competing interests declared.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Pharmaceutical advertisements in medical journals
Is the Subject Area "Pharmaceutical advertisements in medical journals" applicable to this article?

Thanks for your feedback.
Advertising
Is the Subject Area "Advertising" applicable to this article?

Thanks for your feedback.
Medical journals
Is the Subject Area "Medical journals" applicable to this article?

Thanks for your feedback.
Oncology
Is the Subject Area "Oncology" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Drug regulation
Is the Subject Area "Drug regulation" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Safety studies
Is the Subject Area "Safety studies" applicable to this article?

Thanks for your feedback.

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

Reader Comments

Post Your Discussion Comment

Why should this posting be reviewed?

Thank You!

An interesting benchmark

Posted by Athena1 on 10 Sep 2012 at 09:00 GMT